{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T01:29:29Z","timestamp":1788053369340,"version":"build-2784847793"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T00:00:00Z","timestamp":1570579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Jaap Schouten Foundation"},{"name":"Noordwest Academie"},{"DOI":"10.13039\/501100014434","name":"Polish National Agency for Academic Exchange","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aims<\/jats:title><jats:p>To further elucidate the nature of the association between N-terminal pro-B type natriuretic peptide (NT-proBNP), high-sensitivity cardiac troponin T (hs-TnT), C-reactive protein (CRP), and clinical outcome, we examined the relationship between serial simultaneous measurements of echocardiographic parameters and these biomarkers in chronic heart failure (CHF) patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>In 117 CHF patients with ejection fraction \u226450%, NT-proBNP, hs-TnT, and CRP were measured simultaneously with echocardiographic evaluation at 6-month intervals until the end of 30\u2009months follow-up or until an adverse clinical event occurred. Linear mixed effects models were used for data-analysis. Median follow-up was 2.2\u2009years (interquartile range 1.5\u20132.6). We performed up to six follow-up evaluations with 55% of patients having at least three evaluations performed. A model containing all three biomarkers revealed that doubling of NT-proBNP was associated with a decrease in left ventricular ejection fraction by 1.83 (95% confidence interval \u22122.63 to \u22121.03)%, P\u2009&amp;lt;\u20090.0001; relative increase in mitral E\/e\u2032 ratio by 12 (6\u201318)%, P\u2009&amp;lt;\u20090.0001; relative increase in mitral E\/A ratio by 16 (9\u201323)%, P\u2009&amp;lt;\u20090.0001; decrease in tricuspid annular plane systolic excursion by 0.66 (\u22121.27 to \u22120.05) mm, P\u2009=\u20090.03; rise in tricuspid regurgitation peak systolic gradient by 2.74 (1.43\u20134.05) mmHg, P\u2009=\u20090.001; and increase in left ventricular and atrial dimensions, P\u2009&amp;lt;\u20090.05. Hs-TnT and CRP showed significant associations with some echocardiographic parameters after adjustment for clinical covariates, but after adjustment for the other biomarkers the associations were not significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Serum NT-proBNP independently reflects changes in echocardiographic parameters of systolic function, left ventricular filling pressures, estimated pulmonary pressure, and chamber dimensions. Our results support further studies on NT-proBNP as a surrogate marker for haemodynamic congestion and herewith support its potential value for therapy guidance.<\/jats:p><\/jats:sec>","DOI":"10.1093\/ehjci\/jez242","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T19:25:15Z","timestamp":1568143515000},"page":"1005-1012","source":"Crossref","is-referenced-by-count":10,"title":["Longitudinal patterns of N-terminal pro B-type natriuretic peptide, troponin T, and C-reactive protein in relation to the dynamics of echocardiographic parameters in heart failure patients"],"prefix":"10.1093","volume":"21","author":[{"given":"Dominika","family":"Klimczak-Tomaniak","sequence":"first","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"},{"name":"Department of Immunology, Transplantation and Internal Medicine, Transplantation Institute, Medical University of Warsaw, Nowogrodzka 59, 02-006 Warsaw, Poland"},{"name":"Division of Heart Failure and Cardiac Rehabilitation, Medical University of Warsaw, Kondratowicza 8, 03-242 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J","family":"van den Berg","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai","family":"Strachinaru","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Martijn","family":"Akkerhuis","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Baart","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kadir","family":"Caliskan","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier C","family":"Manintveld","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Umans","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Northwest Clinics, Wilhelminalaan 12, 1815 JD Alkmaar, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Geleijnse","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas M","family":"van Dalen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"},{"name":"Department of Cardiology, Franciscus Gasthuis & Vlietland, Kleiweg 500, 3045 PM Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Kardys","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Erasmus MC, University Medical Center Rotterdam, room Na-316, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,9]]},"reference":[{"key":"2020082504470749900_jez242-B1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ahj.2017.10.008","article-title":"Toward personalized risk assessment in patients with chronic heart failure: detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study","volume":"196","author":"van Boven","year":"2018","journal-title":"Am Heart J"},{"key":"2020082504470749900_jez242-B2","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1161\/01.CIR.0000054164.99881.00","article-title":"Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT)","volume":"107","author":"Anand","year":"2003","journal-title":"Circulation"},{"key":"2020082504470749900_jez242-B3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.107.694562","article-title":"Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time","volume":"116","author":"Miller","year":"2007","journal-title":"Circulation"},{"key":"2020082504470749900_jez242-B4","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1161\/01.CIR.0000145158.33801.F3","article-title":"Ongoing myocardial injury in stable severe heart failure: value of cardiac troponin T monitoring for high-risk patient identification","volume":"110","author":"Perna","year":"2004","journal-title":"Circulation"},{"key":"2020082504470749900_jez242-B5","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/01.CIR.0000144310.04433.BE","article-title":"N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients","volume":"110","author":"Bettencourt","year":"2004","journal-title":"Circulation"},{"key":"2020082504470749900_jez242-B6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejheart.2008.01.017","article-title":"BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction","volume":"10","author":"Grewal","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"2020082504470749900_jez242-B7","doi-asserted-by":"crossref","first-page":"45.","DOI":"10.1186\/1476-7120-6-45","article-title":"Myocardial tissue Doppler echocardiography and N-terminal B-type natriuretic peptide (NT-proBNP) in diastolic and systolic heart failure","volume":"6","author":"Knebel","year":"2008","journal-title":"Cardiovasc Ultrasound"},{"key":"2020082504470749900_jez242-B8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/eurheartj\/ehi811","article-title":"NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy","volume":"27","author":"Chen","year":"2006","journal-title":"Eur Heart J"},{"key":"2020082504470749900_jez242-B9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jjcc.2011.11.012","article-title":"Highly sensitive cardiac troponin T in heart failure: comparison with echocardiographic parameters and natriuretic peptides","volume":"59","author":"Kusumoto","year":"2012","journal-title":"J Cardiol"},{"key":"2020082504470749900_jez242-B10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5603\/CJ.a2013.0061","article-title":"Determinants of high sensitivity troponin T concentration in chronic stable patients with heart failure: ischemic heart failure versus non-ischemic dilated cardiomyopathy","volume":"21","author":"Bakal","year":"2014","journal-title":"Cardiol J"},{"key":"2020082504470749900_jez242-B11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1161\/01.CIR.103.3.369","article-title":"Persistently increased serum concentrations of cardiac troponin t in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes","volume":"103","author":"Sato","year":"2001","journal-title":"Circulation"},{"key":"2020082504470749900_jez242-B12","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.amjcard.2005.04.048","article-title":"Usefulness of temporal changes in neurohormones as markers of ventricular remodeling and prognosis in patients with left ventricular systolic dysfunction and heart failure receiving either candesartan or enalapril or both","volume":"96","author":"Yan","year":"2005","journal-title":"Am J Cardiol"},{"key":"2020082504470749900_jez242-B13","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1093\/eurheartj\/ehn309","article-title":"ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)","volume":"29","author":"Dickstein","year":"2008","journal-title":"Eur Heart J"},{"key":"2020082504470749900_jez242-B14","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2020082504470749900_jez242-B15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijcard.2018.06.070","article-title":"Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure","volume":"269","author":"Zhang","year":"2018","journal-title":"Int J Cardiol"},{"key":"2020082504470749900_jez242-B16","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.jacc.2016.09.931","article-title":"Prognostic implications of changes in N-terminal pro-B-type natriuretic peptide in patients with heart failure","volume":"68","author":"Zile","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2020082504470749900_jez242-B17","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/eurheartj\/ehi631","article-title":"NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study","volume":"27","author":"Januzzi","year":"2006","journal-title":"Eur Heart J"},{"key":"2020082504470749900_jez242-B18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2008.04.069","article-title":"Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial)","volume":"52","author":"Masson","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2020082504470749900_jez242-B19","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ehjci\/jex067","article-title":"Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study","volume":"18","author":"Lancellotti","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2020082504470749900_jez242-B20","doi-asserted-by":"crossref","first-page":"126","DOI":"10.14740\/cr362w","article-title":"Reducing heart failure hospital readmissions: a systematic review of disease management programs","volume":"5","author":"Gorthi","year":"2014","journal-title":"Cardiol Res"},{"key":"2020082504470749900_jez242-B21","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.002600","article-title":"Pulmonary artery pressure-guided heart failure management reduces 30-day readmissions","volume":"9","author":"Adamson","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2020082504470749900_jez242-B22","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/j.jacc.2017.01.058","article-title":"Estimating left ventricular filling pressure by echocardiography","volume":"69","author":"Andersen","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2020082504470749900_jez242-B23","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/eurjhf\/hfq045","article-title":"Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine","volume":"12","author":"Gheorghiade","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2020082504470749900_jez242-B24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(15)00723-0","article-title":"Sustained efficacy of pulmonary artery pressure to guide adjustment of chronic heart failure therapy: complete follow-up results from the CHAMPION randomised trial","volume":"387","author":"Abraham","year":"2016","journal-title":"Lancet"},{"key":"2020082504470749900_jez242-B25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijcard.2018.04.049","article-title":"Does natriuretic peptide monitoring improve outcomes in heart failure patients? A systematic review and meta-analysis","volume":"263","author":"Khan","year":"2018","journal-title":"Int J Cardiol"},{"key":"2020082504470749900_jez242-B26","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMra0800239","article-title":"Biomarkers in heart failure","volume":"358","author":"Braunwald","year":"2008","journal-title":"N Engl J Med"},{"key":"2020082504470749900_jez242-B27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006619","article-title":"\u201cMalignant\u201d left ventricular hypertrophy identifies subjects at high risk for progression to asymptomatic left ventricular dysfunction, heart failure, and death: MESA (Multi-Ethnic Study of Atherosclerosis)","volume":"7","author":"Peters","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2020082504470749900_jez242-B28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/MBP.0000000000000297","article-title":"Discerning the relationship between left ventricular geometry, high-sensitivity troponin T, and nondipper hypertension","volume":"23","author":"Askin","year":"2018","journal-title":"Blood Press Monit"},{"key":"2020082504470749900_jez242-B29","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1007\/s00392-017-1152-8","article-title":"Circadian rhythm of blood cardiac troponin T concentration","volume":"106","author":"Fournier","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"2020082504470749900_jez242-B30","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ijcard.2013.01.228","article-title":"Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study","volume":"168","author":"Lassus","year":"2013","journal-title":"Int J Cardiol"},{"key":"2020082504470749900_jez242-B31","doi-asserted-by":"crossref","first-page":"e0157159.","DOI":"10.1371\/journal.pone.0157159","article-title":"Multi-marker strategy in heart failure: combination of ST2 and CRP predicts poor outcome","volume":"11","author":"Dupuy","year":"2016","journal-title":"PLoS One"},{"key":"2020082504470749900_jez242-B32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"key":"2020082504470749900_jez242-B33","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/HJH.0000000000001875","article-title":"Extracellular volume by cardiac magnetic resonance is associated with biomarkers of inflammation in hypertensive heart disease","volume":"37","author":"Pan","year":"2019","journal-title":"J Hypertens"},{"key":"2020082504470749900_jez242-B34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.2009.2","article-title":"BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial","volume":"301","author":"Pfisterer","year":"2009","journal-title":"JAMA"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/21\/9\/1005\/33680263\/jez242.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ehjcimaging\/article-pdf\/21\/9\/1005\/33680263\/jez242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T02:55:49Z","timestamp":1664333749000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/21\/9\/1005\/5584220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,9]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,10,9]]},"published-print":{"date-parts":[[2020,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jez242","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,9]]},"published":{"date-parts":[[2019,10,9]]}}}